| Viva B(y)a |
Pharmacokinetic drug-drug interactions
() |
| Viva B(vii) |
Pharmacokinetics of drugs in the epidural and subarachnoid space
() |
| Viva 7 |
Multicompartement models of drug distribution (using fentanyl as an example)
() |
| Viva 8 |
The effect of ageing on pharmacology
() |
| Viva 7 (p.2) |
Peripheral nervous system and pharmacology of local anaesthetics
() |
| Viva 5 (p.2) |
Renal clearance
() |
| Viva B(i) |
Single and multiple compartment models of drug distribution
() |
| Viva B(ii)a |
Routes of administration; bioavailability and bioequivalence
() |
| Viva B(ii)b |
Drug absorption; transfer of drugs across membranes; lipid solubility of drugs
() |
| Viva B(ii)c |
Gastrointestinal drug absorption, the effect of gastric motility and gut flora
() |
| Viva B(iii) |
Volume of distribution
() |
| Viva B(v) |
Half-life, context sensitive half time and effect site equilibration
() |
| Viva B(iv)a |
Clearance - renal clearance and hepatic clearance
() |
| Viva B(iv)b |
Biotransformation, Phase I and Phase II reactions, elimination kinetics
() |
| Viva B(vi ) |
Maintenance dose, loading dose and plasma drug concentration measurements
() |
| Viva B(y) |
Pharmacokinetics in critical illness, obesity and old age
() |